Gilead Sciences
GILD
$109.98
Share price
-1.15%
Change (1 day)
69.04%
Change (1 year)
Categories
Gilead Sciences (GILD) - Total assets
Total assets on the balance sheet as of March 2025 : $56.43 Billion USD
According to Gilead Sciences's latest financial reports the company's total assets are $56.43 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Gilead Sciences - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $58.99 B | -5.04% |
| 2023-12-31 | $62.12 B | -1.66% |
| 2022-12-31 | $63.17 B | -7.04% |
| 2021-12-31 | $67.95 B | -0.67% |
| 2020-12-31 | $68.40 B | 11% |
| 2019-12-31 | $61.62 B | -3.22% |
| 2018-12-31 | $63.67 B | -9.4% |
| 2017-12-31 | $70.28 B | 23.35% |
| 2016-12-31 | $56.97 B | 10.17% |
| 2015-12-31 | $51.71 B | 49.19% |
| 2014-12-31 | $34.66 B | 53.52% |
| 2013-12-31 | $22.57 B | 6.3% |
| 2012-12-31 | $21.23 B | 22.75% |
| 2011-12-31 | $17.30 B | 49.26% |
| 2010-12-31 | $11.59 B | 19.53% |
| 2009-12-31 | $9.69 B | 39.81% |
| 2008-12-31 | $6.93 B | 18.89% |
| 2007-12-31 | $5.83 B | 42.8% |
| 2006-12-31 | $4.08 B | 8.49% |
| 2005-12-31 | $3.76 B | 74.69% |
| 2004-12-31 | $2.15 B | 38.67% |
| 2003-12-31 | $1.55 B | 20.69% |
| 2002-12-31 | $1.28 B | 62.08% |
| 2001-12-31 | $0.79 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $89.36 B | 58.36% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $22.88 B | -59.46% | 🇺🇸 USA |
 AbbVie ABBV | $136.16 B | 141.28% | 🇺🇸 USA |
 Illumina ILMN | $6.18 B | -89.05% | 🇺🇸 USA |
 Biogen BIIB | $28.03 B | -50.33% | 🇺🇸 USA |
 Pfizer PFE | $208.02 B | 268.62% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $193.67 B | 243.18% | 🇺🇸 USA |
 Eli Lilly LLY | $89.38 B | 58.40% | 🇺🇸 USA |
 Merck MRK | $115.12 B | 103.99% | 🇺🇸 USA |